Elite Pharmaceuticals Inc ELTP:OTCQB

RT Quote | Exchange | USD
Last | 03/02/21 EST
0.0601UNCH (UNCH)
52 week range
0.05 - 0.10

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0601
  • 52 Week High0.10
  • 52 Week High Date04/07/20
  • 52 Week Low0.05
  • 52 Week Low Date11/30/20
  • Market Cap60.66M
  • Shares Out1.009B
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.69
  • 1 Year % Change-30.12

RATIOS/PROFITABILITY

  • EPS (TTM)0.00
  • P/E (TTM)37.80
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)2.807M
  • ROE (MRQ)45.59%
  • Revenue (MRQ)24.94M
  • Gross Margin (MRQ)47.91%
  • Net Margin (MRQ)10.56%
  • Debt To Equity (MRQ)30.61%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Elite Pharmaceuticals Inc News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is principally engaged in the development and manufacture of oral, controlled-release products. The Company develops and manufactures generic products, products using controlled-release drug technology, products utilizing abuse deterrent technologies, and it develops and markets generic controlled-release and abuse deterrent pharmaceutical products. Its segments include Abbreviated New Drug...
Nasrat Hakim
Chairman
Carter Ward CPA
Chief Financial Officer
Douglas Plassche
Executive Vice President
Jason LePree
Vice President
Address
165 Ludlow Ave
Northvale, NJ
07647-2305
United States